Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Reducing unnecessary antibiotic use through antimicrobial stewardship strategies in newborns can lower both antibiotic exposure and mortality rates, especially in low-resource…
Yes, a once-daily bictegravir-lenacapavir single-tablet regimen is non-inferior to complex regimens for maintaining HIV-1 suppression at 48 weeks, based on phase 3 trial data.
Yes, maternal preeclampsia is linked to a modestly higher risk of neonatal sepsis in the first 28 days of life, based on a large meta-analysis.
Nirsevimab is being rolled out for infants in New York City and is recommended for high-risk groups including those living with HIV or exposed to HIV.
In low-income countries, severe RSV outcomes like hospitalization and death peak in infants between 2 and 5 months of age.
Yes, bariatric surgery significantly reduces low back pain in morbidly obese adults, with studies showing major improvements in pain scores and disability.
Yes, the FDA approved valproic acid oral solution for both monotherapy and adjunctive therapy to treat complex partial seizures.
A 2024 trial found that a sequenced care pathway was not superior to a pain navigator for Veterans with low back pain at 3 months.
Yes, valproate sodium injection is an approved intravenous alternative for complex partial seizures when a patient cannot take oral medication temporarily.
Limited evidence from systematic reviews suggests antibiotics may help some people with low back pain and Modic type 1 changes, but results are uncertain and more research is…
FDA approvals for valproic acid and related drugs explicitly cover both complex partial seizures and absence seizures, often allowing use for patients who have multiple seizure…
Yes, valproate sodium injection is FDA-approved for complex partial seizures when oral valproate is temporarily not feasible.
Yes, Focinvez (fosaprepitant) is FDA-approved to prevent chemotherapy-induced nausea and vomiting when used with other antiemetics.
Propolis dry extract is the optimal treatment specifically for preventing moderate-to-severe oral mucositis in breast cancer patients, though zinc is better for overall prevention.
Key risk factors for CINV in breast cancer include younger age (≤45 years), history of motion sickness, and multiple chemotherapy cycles (≥3).
About 48% of breast cancer patients experience chemotherapy-induced nausea and vomiting, with higher risk in younger patients and those with motion sickness history.
Yes, valproic acid oral solution is FDA-approved to be used alone for complex partial seizures.
5-HT3 antagonists and dexamethasone are both effective for CINV, but adding a 5-HT3 antagonist to dexamethasone improves outcomes; guidelines recommend using them together with…
Yes, photobiomodulation significantly reduces the risk of severe oral mucositis in head and neck cancer patients, with a 54% risk reduction shown in a recent meta-analysis.
Yes, zinc supplements may help prevent oral mucositis after chemoradiotherapy, especially when started early and used topically, but evidence is limited.
Yes, photobiomodulation therapy is effective for reducing oral mucositis in cancer patients, with studies showing about a 50% reduction in risk.
Zinc supplements were most effective for reducing overall oral mucositis in breast cancer patients, based on a network meta-analysis of 10 RCTs.
Yes, unilateral selective laser trabeculoplasty (SLT) can lower IOP in the untreated eye, with a mean reduction of about 1.85 mmHg at 3-6 months.
Genetic risk tests for idiopathic pulmonary fibrosis work best for people of European ancestry, but they show limited accuracy for non-European groups because most studies have…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.